BioSpace News Archive

Liht Cannabis Corp. announces that Ms. Linda Sampson wishes to “temporarily withdraw” from the Board of Directors effective immediately.

Endo International plc announced an upsizing of its previously announced cash tender offers and consent solicitations by Endo Finance LLC, a wholly-owned subsidiary of Endo International plc.

Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced that Alan Joslyn, Ph.D., President and CEO of Oragenics, Inc.

Across the United States, millions of individuals face serious, life-limiting illness like cancer, heart disease and stroke, respiratory disease and diabetes.

Implicity, the French leader in remote monitoring of cardiac implantable electronic devices, announces a €4 million fundraising round with the participation of Serena, XAnge, Siparex and CapDecisif Management.

By age 22, Victor C. had tried everything in his battled against severe depression and was losing hope. Last year he found new hope with intravenous ketamine infusions

A Columbia, Missouri company that makes biometrically-controlled virtual escapes for areas of social isolation, situational and employee stress took home a first-place prize this week in the XR category at SXSW.

Redpin Therapeutics, Inc., a gene therapy company leveraging its proprietary chemogenetics platform to advance targeted cell therapies that address currently intractable diseases of the nervous system, today announced the publication of a new paper in the journal Science describing the company’s foundational science.

Both technologies address unmet needs for patients with celiac disease

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, announced the closing of its previously announced offering.